Please login to the form below

Not currently logged in
Email:
Password:

MHRA recalls counterfeit Casodex

The MHRA has issued a recall on a counterfeit batch of AstraZeneca's prostate cancer treatment Casodex tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a recall on a counterfeit batch of AstraZeneca's (AZ) prostate cancer treatment Casodex (bicalutamide) tablets 50mg with the lot number 65520. It is only a matter of days since the MHRA announced a Class 1 recall of French pharmaceutical company sanofi-aventis' anti-thrombosis drug, Plavix (clopidogrel), and signals an increased and sustained attempt by counterfeiters to target the UK drug market.

As with the Plavix alert, the counterfeit Casodex tablets were supplied in French livery through parallel importers. The evidence so far suggests that it has been distributed within the legitimate UK supply chain and may have already reached patients.

Pharmacists have been asked to recover the counterfeit tablets from patients, while the Royal Pharmaceutical Society of Great Britain (RPSGB) has counselled them to check their stock for the counterfeit and to check on the society's website for guidance: http://www.rpsgb.org/pdfs/counterfeitmedsguid.pdf

The MHRA is also investigating a link between the Casodex counterfeits and the recent discovery of counterfeit Zyprexa (olanzapine), which made its way into the UK supply chain through parallel imports from France. Initial MHRA laboratory tests indicate that the counterfeit versions of Casodex contain approximately 75 per cent of the active ingredient, bicalutamide.

Dr Chris Hiley, Head of Policy and Research at The Prostate Cancer Charity, said of the Casodex recall: "We are aware that counterfeit Casodex is available from suppliers over the Internet but have not felt this has been a problem in the UK. This is because the NHS prescription system means that there is no need for men to seek out these suppliers to save money or to afford treatment in the first place."

7th June 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics